My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Catalog No: V0595
    CAS No. (CAS Registry Number): 1221713-92-3
    Description: NPS-1034 (NPS1034; NPS 1034) is a novel, potent dual inhibitor of the tyrosine kinases Met and Axl with potential antineoplastic activity. It inhibits Met and Axl with IC50s of 48 nM and ...
    Catalog No: V0635
    CAS No. (CAS Registry Number): 1037624-75-1
    Description: Bemcentinib (formerly known as BGB324; R428) is a novel, potent and selective inhibitor of the RTK (receptor tyrosine kinase) Axl with potential anticancer activity. It inhibits Axl ...
    Catalog No: V0636
    CAS No. (CAS Registry Number): 1493694-70-4
    Description: UNC2250 (UNC-2250) is a novel, potent and selective Mer inhibitor with potential antitumor activity. It inhibits Mer with an IC50 of 1.7 nM, and shows about 160- and 60-fold higher select...
    Catalog No: V0637
    CAS No. (CAS Registry Number): 1493764-08-1
    Description: UNC2881 (UNC-2881) is a novel, potent and specific Mer tyrosine kinase inhibitor with potential utility for prevention and treatment of pathologic thrombosis. It inhibits Mer with an IC50...
    Catalog No: V0638
    CAS No. (CAS Registry Number): 1361030-48-9
    Description: LDC1267 (LDC-1267) is a novel, highly potent and selective TAM (Tyro3, Axl and Mer) kinase inhibitor with potential antitumor activity. It inhibits Mer, Tyro3, and Axl ...
    Catalog No: V0639
    CAS No. (CAS Registry Number): 1341200-45-0
    Description: Dubermatinib (formerly also known as TP-0903; TP-0903) is a novel, selective and orally bioavailable inhibitor of the AXL receptor tyrosine kinase with potential antineoplastic ...
    Products are for research use only;  We do not sell to patients
    Tel: 1-708-310-1919
    Fax: 1-708-557-7486
    Subscribe to our E-newsletter
    • Name*
    • *
    • E-mail*
    • *
    • instructions:
    • *
    Copyright 2020 InvivoChem LLC | All Rights Reserved